In respect to Austria, prior authorisation provided for by the EU Patient Mobility Directive is required for certain therapies in order to be entitled to the special reimbursement that is governed by this act. No demand for reimbursement can be made, if the service was received, although authorisation had been rejected. More information on the mentioned variants in regard to reimbursement can be found in the fact sheet “Reimbursement”.
As a result of the so-called "cross-divisional service", the application can be submitted to any social insurance carrier.
Prior authorisation is required for the following treatments:
- Inpatient treatment and examinations (at least one overnight stay is required),
- Outpatient treatment and examinations requiring the use of highly specialised and cost-intensive medical infrastructure or medical equipment; these are
- diagnostic and therapeutic applications using radiation or particles such as CT, MRT, magnetic resonance imaging, proton therapy and particle therapy;
- outpatient treatment and examinations using high technology equipment that would be covered by the Austrian Major Equipment Plan;
- cosmetic treatments, for which cover is granted in accordance with § 133 section 3 ASVG;
- human genetic studies;
- surgical procedures that must be performed in a sterile setting;
- treatments that are associated with a particular risk for the patient or the population; or
- treatments that are provided by healthcare providers, which in the individual case may raise serious and specific concerns in terms of the quality or safety of care, with the exception of healthcare provision governed by the European Union legislation on the assurance of a minimum level of safety and a minimum quality throughout the European Union.
The insured person must present documents to the relevant social insurance carrier on
- the type of treatment;
- the therapeutic goal sought;
- the treatment date;
- the healthcare provider, where the treatment will be received; and
- records about the medical condition that will permit an evaluation of the urgency of the treatment.